- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/33 - AntibodiesT-cell engagers
Patent holdings for IPC class A61K 40/33
Total number of patents in this class: 79
10-year publication summary
|
2
|
1
|
1
|
0
|
0
|
4
|
2
|
3
|
32
|
20
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dana-Farber Cancer Institute, Inc. | 2646 |
4 |
| The Regents of the University of California | 20611 |
3 |
| The General Hospital Corporation | 4845 |
2 |
| Hospital Clinic de Barcelona | 142 |
2 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3335 |
2 |
| National University of Singapore | 2567 |
2 |
| Roswell Park Cancer Institute Corp. | 18 |
2 |
| Whitehead Institute for Biomedical Research | 325 |
2 |
| Surrozen Operating, Inc. | 51 |
2 |
| Fundación Cris de Investigación para Vencer El Cáncer | 2 |
2 |
| Hoffmann-La Roche Inc. | 3738 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6621 |
1 |
| The Johns Hopkins University | 5849 |
1 |
| The Trustees of Columbia University in the City of New York | 3629 |
1 |
| The Trustees of the University of Pennsylvania | 4405 |
1 |
| Georgia Tech Research Corporation | 2918 |
1 |
| Duke University | 3169 |
1 |
| Northwestern University | 3528 |
1 |
| Abclon Inc. | 34 |
1 |
| Amgen Research (Munich) GmbH | 262 |
1 |
| Other owners | 46 |